$RGBP Regen is also party to an agreement whereby
Post# of 7058
(Total Views: 423)
Posted On: 03/02/2017 10:36:05 AM
$RGBP Regen is also party to an agreement whereby Zander Therapeutics, Inc. has been granted by Regen, an exclusive worldwide right and license for the development and commercialization of NR2F6 intellectual property controlled by Regen for non-human veterinary therapeutic use. Zander Therapeutics Inc. is a wholly-owned subsidiary of Entest BioMedical Inc. (ENTB). David R. Koos serves as Chairman and Chief Executive Officer of Regen, Entest Biomedical, Inc. and Zander Therapeutics.
https://finance.yahoo.com/news/regen-biopharm...00603.html
https://finance.yahoo.com/news/regen-biopharm...00603.html
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Scroll down for more posts ▼